Acceleron Pharma Inc. (NASDAQ: XLRN) was started as Outperform with a $44 price target at Oppenheimer.

AGCO Corp. (NYSE: AGCO) was downgraded to Hold from Buy and the $61 price target was maintained (and achieved, $60.27 close) at Jefferies.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) was downgraded to Equal Weight from Overweight at Morgan Stanley.

Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) was downgraded to Underweight from Equal Weight with a $10 price target (versus a $10.99 close) at Morgan Stanley.

Buffalo Wild Wings (NASDAQ: BWLD) was downgraded to Market Perform from Outperform with a $185 price target (versus a $174.25 close) at BMO Capital Markets.

Cerner Corp. (NASDAQ: CERN) was downgraded to Underweight from Equal Weight with a $45 price target (versus a $48.89 close) at Morgan Stanley.

DaVita Inc. (NYSE: DVA) was downgraded to Neutral from Outperform with a $69 price target (versus a $66.59 close) at Robert W. Baird.

GNC Holdings Inc. (NYSE: GNC) was downgraded to Underweight from Equal Weight with an $11 price target (versus a $13.91 close) at Barclays.

Jacobs Engineering Group Inc. (NYSE: JEC) was downgraded to Hold from Buy at Jefferies, based on more balanced risk/reward.

MEDNAX Inc. (NYSE: MD) was downgraded to Hold from Buy at Jefferies, noting that it is difficult to see the company delivering outsized gains from here.

Medical Properties Trust (NYSE: MPW) was downgraded to Underperform from Market Perform at Wells Fargo.

PPG Industries Inc. (NYSE: PPG) was downgraded to Sector Perform from Outperform with a $101 price target (versus a $98.65 close) at RBC Capital Markets.

Senior Housing Properties Trust (NYSE: SNH) was downgraded to Underperform from Market Perform at Wells Fargo.

Smart Sand Inc. (NASDAQ: SND) was started with a Buy rating and assigned an $18 price target (versus a $13.90 close) at Jefferies.

Team Health Holdings Inc. (NYSE: TMH) was downgraded to Hold from Buy at Jefferies, noting that they see little upside versus Blackstone’s takeout offer.

Twenty-First Century Fox Inc. (NASDAQ: FOXA) was maintained as Outperform, but the price target was cut to $31 from $33, at Wedbush. The target was cut based on likely terms of the deal for Sky in the United Kingdom.

WellCare Health Plans Inc. (NYSE: WCG) was downgraded to Neutral from Buy at Goldman Sachs.

Oppenheimer sees 2017 and 2018 as Goldilocks years for the banks.

Merrill Lynch raised its price targets on top steel stocks.

Merrill Lynch made some changes in its RIC Report for December: Themes for 2017 are shaped by policy changes from the new political leadership and the fundamentals that have been in place; they favor cyclicals in equities over defensives including energy and financials; and it increased its allocation to small caps to overweight from underweight. They also apply defensive strategies in bonds but trimmed its allocation to TIPS.

Monday’s top analyst upgrades and downgrades included AMD, CVS Health, ConocoPhillips, EOG Resources, Seattle Genetics, WebMD and over a dozen more.